Scarica l'app Stockscreener
7.54
3.01%
0.22
Dopo l'orario di chiusura:
7.54
Precedente Chiudi:
$7.32
Aprire:
$7.38
Volume 24 ore:
286.98K
Relative Volume:
0.44
Capitalizzazione di mercato:
$407.85M
Reddito:
$2.81M
Utile/perdita netta:
$-97.34M
Rapporto P/E:
-4.7722
EPS:
-1.58
Flusso di cassa netto:
$-91.47M
1 W Prestazione:
+7.87%
1M Prestazione:
+13.55%
6M Prestazione:
+149.67%
1 anno Prestazione:
+119.19%
Intervallo 1D:
$7.25
$7.65
Intervallo di 1 settimana:
$6.6901
$7.65
Portata 52W:
$2.315
$8.50
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
Nome
Fulcrum Therapeutics Inc
Settore
Industria
Telefono
617-651-8851
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Confronta FULC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
7.54 | 395.95M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-29 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-09-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | Downgrade | Stifel | Buy → Hold |
| 2024-09-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-09-25 | Iniziato | Goldman | Neutral |
| 2023-08-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | Aggiornamento | Stifel | Hold → Buy |
| 2023-05-04 | Downgrade | Goldman | Buy → Neutral |
| 2023-03-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | Downgrade | Stifel | Buy → Hold |
| 2023-02-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-11-15 | Iniziato | Goldman | Buy |
| 2022-03-08 | Iniziato | Oppenheimer | Outperform |
| 2022-03-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-08-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-22 | Iniziato | Credit Suisse | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2020-10-16 | Iniziato | Piper Sandler | Overweight |
| 2020-08-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2019-10-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-12 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
Acadian Asset Management LLC Increases Stock Position in Fulcrum Therapeutics, Inc. $FULC - Defense World
Jacobs Levy Equity Management Inc. Purchases New Shares in Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Here's Why We're Not Too Worried About Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation - Yahoo Finance
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Aug PostEarnings: Will Fulcrum Therapeutics Inc outperform tech stocksTrade Analysis Summary & Community Verified Trade Signals - خودرو بانک
Risk Check: Can Fulcrum Therapeutics Inc disrupt its industry2025 Breakouts & Breakdowns & Daily Profit Focused Stock Screening - خودرو بانک
Fulcrum reduces its workforce - MSN
Published on: 2025-09-16 21:20:39 - خودرو بانک
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Update - MarketBeat
Trading Action: Will Immunocore Holdings plc Depositary Receipt outperform tech stocksTrade Analysis Summary & Free Expert Verified Stock Movement Alerts - خودرو بانک
Guidance Update: Can Fulcrum Therapeutics Inc keep up with sector leadersJuly 2025 Review & Safe Swing Trade Setup Alerts - خودرو بانک
Technical analysis overview for Fulcrum Therapeutics Inc. stock2025 Key Highlights & Consistent Return Investment Signals - newser.com
Published on: 2025-09-16 05:16:04 - خودرو بانک
Market Overview: Is IF Bancorp Inc in a long term uptrendStock Surge & High Yield Equity Trading Tips - خودرو بانک
Aug Update: Is Fulcrum Therapeutics Inc in a bullish channelWeekly Investment Recap & Free Technical Confirmation Trade Alerts - خودرو بانک
Market Catalysts: Is Fulcrum Therapeutics Inc benefiting from innovation trendsJuly 2025 Patterns & Expert Approved Momentum Ideas - خودرو بانک
Applying chart zones and confluence areas to Fulcrum Therapeutics Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com
Fulcrum Therapeutics, Inc. $FULC Shares Bought by Exome Asset Management LLC - MarketBeat
Published on: 2025-09-15 03:06:05 - newser.com
Using flow based indicators on Fulcrum Therapeutics Inc.2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Volume spikes in Fulcrum Therapeutics Inc. stock – what they meanPortfolio Return Report & Technical Entry and Exit Tips - newser.com
147,654 Shares in Fulcrum Therapeutics, Inc. $FULC Acquired by Jacobs Levy Equity Management Inc. - Defense World
Institutional scanner results for Fulcrum Therapeutics Inc.Market Growth Summary & Stepwise Trade Execution Plans - Newser
Is Fulcrum Therapeutics Inc. reversing from oversold territoryJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Invesco Ltd. Acquires 55,791 Shares of Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Short interest data insights for Fulcrum Therapeutics Inc.Insider Buying & Technical Confirmation Trade Alerts - Newser
Fulcrum Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Top chart patterns to watch in Fulcrum Therapeutics Inc.Market Movers & Low Drawdown Momentum Trade Ideas - Newser
Will a bounce in Fulcrum Therapeutics Inc. offer an exitTrade Exit Summary & Risk Controlled Stock Alerts - Newser
What’s next for Fulcrum Therapeutics Inc. stock priceJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Real time breakdown of Fulcrum Therapeutics Inc. stock performanceTrade Signal Summary & Entry Point Strategy Guides - Newser
Fulcrum Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
How to use Fibonacci retracement on Fulcrum Therapeutics Inc.July 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - Newser
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Custom watchlist performance reports with Fulcrum Therapeutics Inc.2025 Pullback Review & Long Hold Capital Preservation Tips - Newser
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing recovery setups for Fulcrum Therapeutics Inc. investorsStop Loss & Daily Stock Trend Reports - Newser
Will Fulcrum Therapeutics Inc. benefit from macro trendsWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
What institutional flow reveals about Fulcrum Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Is this a good reentry point in Fulcrum Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Is Fulcrum Therapeutics Inc. stock entering bullish territoryJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Fulcrum Therapeutics Inc. stock prediction for this weekIndex Update & Safe Entry Zone Tips - Newser
Market reaction to Fulcrum Therapeutics Inc.’s recent newsJuly 2025 Technicals & Technical Pattern Alert System - Newser
Combining machine learning predictions for Fulcrum Therapeutics Inc.Market Volume Report & Daily Entry Point Trade Alerts - Newser
Strategies to average down on Fulcrum Therapeutics Inc.July 2025 Technicals & Verified Entry Point Signals - Newser
How sentiment analysis helps forecast Fulcrum Therapeutics Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser
Fulcrum Therapeutics Inc. stock daily chart insightsJuly 2025 Setups & Weekly High Return Forecasts - Newser
Using Bollinger Bands to evaluate Fulcrum Therapeutics Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Has Fulcrum Therapeutics Inc. formed a bullish divergence2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Fulcrum Therapeutics Inc Azioni (FULC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):